Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Howe

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Plos One|April 30, 2024
The implicit power of positive thinking: The effect of positive episodic simulation on implicit future expectanciesRachel J Anderson, J Helgi Clayton McClure, Emma Bishop, et al.
Blood|July 29, 2008
Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansionYu-Waye Chu, Sabrina Schmitz, Baishakhi Choudhury, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 2, 2014
Induced CD8+FoxP3+ Treg cells in rheumatoid arthritis are modulated by p38 phosphorylation and monocytes expressing membrane tumor necrosis factor α and CD86Shawn D P Ellis, Jenny L McGovern, André van Maurik, et al.
Endocrinology|May 13, 2006
Regulation of membrane-associated prostaglandin E2 synthase 1 in pregnant sheep intrauterine tissues by glucocorticoid and estradiolQi Zhang, Valta Collins, Kaushik Chakrabarty, et al.
Developmental Medicine and Child Neurology|September 5, 2021
Antenatal counselling for prospective parents whose fetus has a neurological anomaly: part 2, risks of adverse outcome in common anomaliesAnthony R Hart, Chakra Vasudevan, Paul D Griffiths, et al.
Developmental Medicine and Child Neurology|August 23, 2021
Antenatal counselling for prospective parents whose fetus has a neurological anomaly: part 1, experiences and recommendations for service designAnthony R Hart, Brigitte Vollmer, David Howe, et al.
The Journal of Antimicrobial Chemotherapy|August 5, 2022
Potency of the novel PolC DNA polymerase inhibitor CRS0540 in a disseminated Listeria monocytogenes intracellular hollow-fibre modelSwati Patel, Moti Chapagain, Clifford Mason, et al.
European Journal of Endocrinology|December 20, 2023
A novel somatostatin receptor ligand for human ACTH - and GH -secreting pituitary adenomasDaniela Regazzo, Serena Avallone, Cliona P MacSweeney, et al.
British Journal of Clinical Pharmacology|June 2, 2022
Phase 1 and preclinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaeniaRebecca C Furze, Judit Molnar, Nigel J Parr, et al.
Clinical Pharmacology and Therapeutics|December 20, 2023
A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary DiseaseFred Reid, Dave Singh, Muna Albayaty, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Plos One|April 30, 2024
The implicit power of positive thinking: The effect of positive episodic simulation on implicit future expectanciesRachel J Anderson, J Helgi Clayton McClure, Emma Bishop, et al.
Blood|July 29, 2008
Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansionYu-Waye Chu, Sabrina Schmitz, Baishakhi Choudhury, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 2, 2014
Induced CD8+FoxP3+ Treg cells in rheumatoid arthritis are modulated by p38 phosphorylation and monocytes expressing membrane tumor necrosis factor α and CD86Shawn D P Ellis, Jenny L McGovern, André van Maurik, et al.
Endocrinology|May 13, 2006
Regulation of membrane-associated prostaglandin E2 synthase 1 in pregnant sheep intrauterine tissues by glucocorticoid and estradiolQi Zhang, Valta Collins, Kaushik Chakrabarty, et al.
Developmental Medicine and Child Neurology|September 5, 2021
Antenatal counselling for prospective parents whose fetus has a neurological anomaly: part 2, risks of adverse outcome in common anomaliesAnthony R Hart, Chakra Vasudevan, Paul D Griffiths, et al.
Developmental Medicine and Child Neurology|August 23, 2021
Antenatal counselling for prospective parents whose fetus has a neurological anomaly: part 1, experiences and recommendations for service designAnthony R Hart, Brigitte Vollmer, David Howe, et al.
The Journal of Antimicrobial Chemotherapy|August 5, 2022
Potency of the novel PolC DNA polymerase inhibitor CRS0540 in a disseminated Listeria monocytogenes intracellular hollow-fibre modelSwati Patel, Moti Chapagain, Clifford Mason, et al.
European Journal of Endocrinology|December 20, 2023
A novel somatostatin receptor ligand for human ACTH - and GH -secreting pituitary adenomasDaniela Regazzo, Serena Avallone, Cliona P MacSweeney, et al.
British Journal of Clinical Pharmacology|June 2, 2022
Phase 1 and preclinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaeniaRebecca C Furze, Judit Molnar, Nigel J Parr, et al.
Clinical Pharmacology and Therapeutics|December 20, 2023
A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary DiseaseFred Reid, Dave Singh, Muna Albayaty, et al.
Pageof 6